Dubai: More than 6,000 volunteers in Bahrain will be part of the world’s first clinical trial for the third possible coronavirus vaccines indexed through WHO.
The Al Bilad newspaper reported that Bahrain had begun 3 clinical trials for a COVID-19 vaccine.
Covid-19 vaccine trials showed an efficacy review of new knowledge and were presented with 21 applicants in Phase III clinical trials.
These main points were shared through Dr. Rodney Hoff, a clinical professor at the University of Washington, a key webinar organized through the United States Embassy in Bahrain.
Dr. Hoff reiterated that the progression of a Covid-19 vaccine is complex in nature and that a vaccine until the end of the year would possibly be imaginable but unlikely. However, the public can expect access to the vaccine until 2021.
Dr. Manaf Al Qahtani, an infectious disease representative and microbiologist at BDF Hospital and a member of the National Working Group on Coronavirus (COVID-19) last month, revealed that many meetings on safe vaccines had been held in gigantic quantities.
A randomized controlled trial ended up using convalescent plasma treatment with some other planned ER on favipiravir, Dr. Manaf said. Multiple observation studies have been conducted with others in progress.
With this in mind, Alba has been proactive in COVID-19 mitigation efforts in Bahrain, presenting and encouraging its network engagement initiatives, including the Convalescent Plasma Donation Program at BDF Royal Medical Services (BDFRMS), led through Major General Shaikh Khalid bin Ali Al Khalifa, Director of Royal Medical Services.
“The Kingdom of Bahrain has been cautious in its technique to combat opposite COVID-19. We are pleased that Alba has demonstrated a strong initiative to BDFRMS through the ‘Convalescent Plasma Donation Program’, which has shown promising effects on the control of PATIENTS with COVID-19,” said Dr. Abdulla Darwish, Technical Assistant to the Director of Royal Medical Services at Bahrain Defence Forces Hospital (BDF).
The “convalescence plasma donation program” is helping to facilitate recovery by moving fully recovered blood plasma antibodies from COVID-19 patients who qualify for existing patients.
Dear reader,
This segment is about life in the United Arab Emirates and data you cannot live without.
Sign up to read and complete gulfnews.com